Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide adjuvant treatment decisions in breast cancer?
- PMID: 14610047
- DOI: 10.1200/JCO.2003.07.966
Reversible ovarian ablation or chemotherapy: are we ready for quality of life to guide adjuvant treatment decisions in breast cancer?
Comment on
-
Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.J Clin Oncol. 2003 Dec 15;21(24):4510-6. doi: 10.1200/JCO.2003.11.064. Epub 2003 Nov 10. J Clin Oncol. 2003. PMID: 14610048 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
